Paper Details

  1. Home
  2. Paper Details

Vigabatrin for refractory partial epilepsy.

Author: HemmingKarla, HuttonJane L, MaguireMelissa J, MarsonAnthony G

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Vigabatrin, an antiepileptic drug for refractory epilepsy, is generally well-tolerated. However, long-term use has been associated with asymptomatic visual field constriction, highlighting the need for monitoring during treatment.
Paper Details　
Original Abstract of the Article :
Epilepsy is a common neurological condition which affects between 0.5% and 1% of the population. Approximately 30% of people with epilepsy do not respond to treatment with currently available drugs, and the majority of these people have partial epilepsy. Vigabatrin is an antiepileptic drug licensed ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD007302

データ提供：米国国立医学図書館（NLM）

Vigabatrin: A Potential Solution for Refractory Epilepsy

The world of [neurology] is a vast and intricate desert, and one of the many challenges we face is finding effective treatments for [epilepsy]. This study explores the use of [vigabatrin] for treating [refractory partial epilepsy], a condition that often resists conventional treatment approaches.

Vigabatrin Shows Promise for Refractory Epilepsy

The researchers discovered that vigabatrin is a promising treatment option for patients with refractory partial epilepsy. This is like finding a precious oasis in a vast and unforgiving desert, offering hope and potential relief. However, they also identified a potential side effect: asymptomatic visual field constriction.

Navigating the Potential Side Effects of Vigabatrin

While vigabatrin holds promise, it's important to be aware of its potential side effects. This is like navigating a desert at night, where it's essential to have a guide to prevent missteps. Close monitoring and collaboration with a healthcare provider are essential for ensuring the safe and effective use of this medication.

Dr.Camel's Conclusion

This study offers a glimmer of hope for individuals struggling with refractory epilepsy. Vigabatrin's potential benefits must be carefully weighed against its possible side effects. By working closely with healthcare professionals and staying informed, we can navigate the challenges of epilepsy with greater confidence and well-being.

Date :
  1. Date Completed 2008-10-15
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

18646179

DOI: Digital Object Identifier

10.1002/14651858.CD007302

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.